Sign in
Taking people in United StatesNo phase

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

Key facts

Who runs it
Mount Sinai Hospital, Canada
Where
Dayton, Phoenix, and San Antonio, United StatesSee the 3 sitesAlso in 4 other countries, 19 sites
Trial code
Status
Recruiting
People taking part
550 people, planned
Started
6 Feb 2023
Expected to end
31 Mar 2028
Type of study
Observational, 2 groups
Treatments tested
  • Dopamine
  • Norepinephrine
Record updated
16 October 2026

Who can take part

Age
21 weeks to 32 weeks
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • ≤32 weeks gestational age and > 48 hours of life
  • Receiving primary vasopressor therapy with Dopamine or Norepinephrine in the context of suspected late-onset sepsis or necrotizing enterocolitis with systemic hypotension (defined as: culture positive or negative bloodstream infection)

Who cannot take part

  • Receiving primary therapy with agents other than Dopamine or Norepinephrine
  • Known chromosomal or genetic anomalies

Where in United States

Also in 4 other countries, 19 sites

  • Dayton Children's HospitalDayton, United StatesContact: Shreyas AryaTaking people
  • Banner-University Medical Center PhoenixPhoenix, United StatesContact: Suma RaoNot yet recruiting
  • Methodist HealthcareSan Antonio, United StatesContact: Melissa Althouse, MDTaking people

About the trial

What the trial wants to find out

Fluid-unresponsive hypotension needing cardiotropic drug treatment is a serious complication in very preterm neonates with suspected late-onset sepsis (LOS; defined as culture positive or negative bloodstream infection or necrotizing enterocolitis occurring >48 hours of age). In Canada, ~250 very preterm neonates receive cardiotropic drugs for LOS related fluid-unresponsive hypotension every year; of these ~35-40% die. Unlike for adult patients, there is little evidence to inform practice. While several medications are used by clinicians, the most frequently used medications are Dopamine (DA) and Norepinephrine (NE). However, their relative impact on patient outcomes and safety is not known resulting in significant uncertainty and inter- and intra-unit variability in practice. Conducting large randomized trials in this subpopulation can be operationally challenging and expensive. Comparative effectiveness research (CER), is a feasible alternative which can generate high-quality real-world evidence using real-world data, by comparing the impact of different clinical practices.

Read full original descriptionShow less

Aim: To conduct an international CER study, using a pragmatic clinical trial design, in conjunction with the existing infrastructure of the Canadian Neonatal Network to identify the optimal management of hypotension in very preterm neonates with suspected LOS.

Objective: To compare the relative effectiveness and safety of pharmacologically equivalent dosages of DA versus NE for primary pharmacotherapy for fluid-unresponsive hypotension in preterm infants born ≤ 32 weeks gestational age with suspected LOS.

Hypothesis: Primary treatment with NE will be associated with a lower mortality

Methods: This CER project will compare management approach at the unit-level allowing inclusion of all eligible patients admitted during the study period. 16 centers in Canada, 2 centers in Ireland, 1 center in each of Israel, Spain and the UK, and 6 centers in the United States have agreed to standardize their practice. All eligible patients deemed circulatory insufficient will receive fluid therapy (minimum 10-20 cc/kg). If hypotension remains unresolved:

Dopamine Units: start at 5mics/kg/min, increase every 16-30 minutes by 5 mics/kg/min to a maximum dose of 15 mics/kg/min or adequate response

Norepinephrine Units: start at 0.05 mics/kg/min, increase every 16-30 minutes by 0.05 mics/kg/min to maximum dose of 0.15/mics/kg/min or adequate response

The 2 groups in the trial

  • Dopamine Units

    Units who have standardized their practice with the use of Dopamine as a first line agent.

    Treatment: Dopamine

  • Norepinephrine Units

    Units who have standardized their practice with the use of Norepinephrine as a first line agent.

    Treatment: Norepinephrine

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis: An International Comparative Effectiveness Research Project
Record updated
16 October 2026